Trial
NCT02553330
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Incyte Corporation
Collaborators
—
Condition
Alopecia Areata
Intervention
Placebo Cream
Why stopped
The study was terminated early based on the results of a planned interim analysis.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-12-16